Organ transplantation—how much of the promise has been realized? (original) (raw)

• Medawar, P.B. The behavior and fate of skin autografts and skin homografts in rabbits. J. Anat. 78, 176 (1944).
  CAS PubMed PubMed Central Google Scholar
• Owen, R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102, 400–401 (1945).
  Article CAS PubMed Google Scholar
• Billingham, R.E., Brent, L. & Medawar, P.B. Actively acquired tolerance of foreign cells. Nature 172, 603–606 (1953).
  Article CAS PubMed Google Scholar
• Murray, J.E., Merrill, J.P. & Harrison, J.H. Renal homotransplantation in identical twins. Surg. Forum 6, 432 (1955).
  Google Scholar
• Port, F., Wolfe, R., Mauger, E., Berling, D. & Jiang, K. Comparison of Survival Probablities for Dialysis Pateints vs Cadeveric Renal Transplant Recipients. J. Am. Med. Assoc. 270, 1339–1343 (1993).
  Article CAS Google Scholar
• Meier-Kriesche, H.U., Schold, J.D. & Kaplan, B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am. J. Transplant. 4, 1289–1295 (2004).
  Article PubMed Google Scholar
• Suchin, E.J. et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166, 973–981 (2001).
  Article CAS PubMed Google Scholar
• Opelz, G. Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation 40, 240–243 (1985).
  Article CAS PubMed Google Scholar
• Cecka, J.M. The UNOS Renal Transplant Registry. in Clinical Transplants 2002 (ed. Cecka, J.M.a.T., P. I.) 1–20 (UCLA Immunogenetics Center, Los Angeles, 2002).
  Google Scholar
• Goulmy, E., Gratama, J.W., Blokland, E., Zwaan, F.E. & van Rood, J.J. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 302, 156–161 (1983).
  Article Google Scholar
• Linsley, P.S., Clark, E.A. & Ledbetter, J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl Acad. Sci. USA 87, 5031–5035 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Freeman, G.J. et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907–909 (1993).
  Article CAS PubMed Google Scholar
• Durie, F.H. et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261, 1328–1330 (1993).
  Article CAS PubMed Google Scholar
• Libby, P. & Pober, J.S. Chronic rejection. Immunity 14, 387–397 (2001).
  Article CAS PubMed Google Scholar
• Russell, P.S. et al. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J. Immunol. 167, 5731–5740 (2001).
  Article CAS PubMed Google Scholar
• Kirk, A.D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5, 686–693 (1999).
  Article CAS PubMed Google Scholar
• Thomas, J.M. et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 69, 2497–2503 (2000).
  Article CAS PubMed Google Scholar
• Kawai, T. et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68, 1767–1775 (1999).
  Article CAS PubMed Google Scholar
• Ildstad, S.T. & Sachs, D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168–170 (1984).
  Article CAS PubMed Google Scholar
• Sharabi, Y. & Sachs, D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparativew regimen. J. Exp. Med. 169, 493–502 (1989).
  Article CAS PubMed Google Scholar
• Kawai, T. et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59, 256–262 (1995).
  Article CAS PubMed Google Scholar
• Spitzer, T.R. et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68, 480–484 (1999).
  Article CAS PubMed Google Scholar
• Buhler, L.H. et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74, 1405–1409 (2002).
  Article PubMed Google Scholar
• Wekerle, T. et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med. 6, 464–469 (2000).
  Article CAS PubMed Google Scholar
• Durham, M.M. et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J. Immunol. 165, 1–4 (2000).
  Article CAS PubMed Google Scholar
• June, C.H., Bluestone, J.A., Nadler, L.M. & Thompson, C.B. The B7 and CD28 receptor families. Immunol. Today 15, 321–331 (1994).
  Article CAS PubMed Google Scholar
• Linsley, P.S. et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174, 561–569 (1991).
  Article CAS PubMed Google Scholar
• Lin, H. et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178, 1801–1806 (1993).
  Article CAS PubMed Google Scholar
• Larsen, C.P. et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61, 4–9 (1996).
  Article CAS PubMed Google Scholar
• Hancock, W.W. et al. Costimulatory function and expression of CD40-ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl Acad. Sci. USA 93, 13967–13972 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Kirk, A. et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl Acad. Sci. USA 94, 8789–8794 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Levisetti, M. et al. Immunosuppressive effects of hCTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159, 5187–5191 (1997).
  CAS PubMed Google Scholar
• Montgomery, S.P. et al. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. Transplantation 74, 1365–1369 (2002).
  Article CAS PubMed Google Scholar
• Kirk, A.D. et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76, 120–129 (2003).
  Article CAS PubMed Google Scholar
• Elzey, B.D. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19, 9–19 (2003).
  Article CAS PubMed Google Scholar
• Abrams, J.R. et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103, 1243–1252 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kremer, J.M. et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349, 1907–1915 (2003).
  Article CAS PubMed Google Scholar
• Larsen, C.P. et al. Rational development of LEA29Y (belatacept), a high affinity variant of CTLA4Ig with potent immunosuppressive properties. Am. J. Transplant. 5, 443–453 (2005).
  Article CAS PubMed Google Scholar
• Rothstein, D.M. & Sayegh, M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196, 85–108 (2003).
  Article CAS PubMed Google Scholar
• Pearson, T.C., Madsen, J.C., Larsen, C.P., Morris, P.J. & Wood, K.J. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 54, 475–483 (1992).
  Article CAS PubMed Google Scholar
• Qin, S. et al. “Infectious” transplantation tolerance. Science 259, 974–977 (1993).
  Article CAS PubMed Google Scholar
• Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
  Article CAS PubMed Google Scholar
• Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ozkaynak, E. et al. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169, 6546–6553 (2002).
  Article CAS PubMed Google Scholar
• Li, Y. et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. 5, 1298–1302 (1999).
  Article CAS PubMed Google Scholar
• Dai, Z., Konieczny, B.T., Baddoura, F.K. & Lakkis, F.G. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J. Immunol. 161, 1659–1663 (1998).
  CAS PubMed Google Scholar
• Larsen, C.P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434–438 (1996).
  Article CAS PubMed Google Scholar
• Wells, A.D. et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5, 1303–1307 (1999).
  Article CAS PubMed Google Scholar
• Kurtz, J. et al. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Blood 103, 4336–4343 (2004).
  Article CAS PubMed Google Scholar
• Benjamin, R.J. & Waldmann, H. Induction of tolerance by monoclonal antibody therapy. Nature 320, 449–451 (1986).
  Article CAS PubMed Google Scholar
• Waldmann, H. & Cobbold, S. Regulating the immune response to transplants. a role for CD4+ regulatory cells? Immunity 14, 399–406 (2001).
  Article CAS PubMed Google Scholar
• Moses, R.D., Sundeen, J.T., Orr, K.S., Roberts, R.R. & Gress, R.E. Cardiac allograft survival across major histocompatibility complex barriers in the rhesus monkey following T lymphocyte-depleted autologous marrow transplantation. III. Late allograft rejection. Transplantation 48, 769–773 (1989).
  Article CAS PubMed Google Scholar
• Holcombe, H., Mellman, I., Janeway, C.A., Jr, Bottomly, K. & Dittel, B.N. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation. J. Immunol. 169, 4982–4989 (2002).
  Article PubMed Google Scholar
• Armstrong, N. et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3–CRM9. Transplantation 66, 5–13 (1998).
  Article CAS PubMed Google Scholar
• Starzl, T.E. et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361, 1502–1510 (2003).
  Article PubMed PubMed Central Google Scholar
• Knechtle, S.J. et al. Campath-1H in renal transplantation: The University of Wisconsin experience. Surgery 136, 754–760 (2004).
  Article PubMed Google Scholar
• Kirk, A.D. et al. Results from a human tolerance trial using CAMPATH-1H with and without infliximab. Am. J. Transplant. 2 Suppl 3, 379 (2002).
  Google Scholar
• Pearl, J.P. et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5, 465–474 (2005).
  Article CAS PubMed Google Scholar
• Sykes, M. Mixed chimerism and transplant tolerance. Immunity 14, 417–424 (2001).
  Article CAS PubMed Google Scholar
• Tang, Q. et al. _In vitro_-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Munn, D.H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867–1870 (2002).
  Article CAS PubMed Google Scholar
• Munn, D.H., Sharma, M.D. & Mellor, A.L. Ligation of B7–1/B7–2 by human CD4(+) T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100–4110 (2004).
  Article CAS PubMed Google Scholar
• Mirenda, V. et al. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 15, 987–997 (2004).
  Article CAS PubMed Google Scholar
• Zheng, X.X. et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19, 503–514 (2003).
  Article CAS PubMed Google Scholar
• Heeger, P.S. et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163, 2267–2275 (1999).
  CAS PubMed Google Scholar
• Padovan, E. et al. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262, 422–424 (1993).
  Article CAS PubMed Google Scholar
• Lombardi, G. et al. Are primary alloresponses truly primary? Int. Immunol. 2, 9–13 (1990).
  Article CAS PubMed Google Scholar
• Murali-Krishna, K. & Ahmed, R. Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165, 1733–1737 (2000).
  Article CAS PubMed Google Scholar
• Gudmundsdottir, H. & Turka, L.A. A closer look at homeostatic proliferation of CD4(+) T cells: costimulatory requirements and role in memory formation. J. Immunol. 167, 3699–3707 (2001).
  Article CAS PubMed Google Scholar
• Ge, Q., Hu, H., Eisen, H.N. & Chen, J. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc. Natl Acad. Sci. USA 99, 2989–2994 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Fan, X. et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat. Med. 10, 1227–1233 (2004).
  Article CAS PubMed Google Scholar
• Gloor, J.M. et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am. J. Transplant. 3, 1017–1023 (2003).
  Article PubMed Google Scholar
• Yang, Y.G. et al. Tolerization of anti-Galalpha1–3Gal natural antibody-forming B cells by induction of mixed chimerism. J. Exp. Med. 187, 1335–1342 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ohdan, H., Swenson, K.G., Kitamura, H., Yang, Y.G. & Sykes, M. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation 8, 227–238 (2001).
  Article CAS PubMed Google Scholar
• Tryphonopoulos, P. et al. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am. J. Transplant. 5, 608–613 (2005).
  Article PubMed Google Scholar
• Oike, F. et al. Complete withdrawal of immunosuppression in living donor liver transplantation. Transplant. Proc. 34, 1521 (2002).
  Article PubMed Google Scholar
• Harper, A.M., Taranto, S.E. & Edwards, E.B. The OPTN waiting list, 1988–2001. Clin. Transpl., 79–92 (2002).
• Cascalho, M. & Platt, J.L. The immunological barrier to xenotransplantation. Immunity 14, 437–446 (2001).
  Article CAS PubMed Google Scholar
• McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1, 423–427 (1995).
  Article CAS PubMed Google Scholar
• Kolber-Simonds, D. et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. Natl Acad. Sci. USA 101, 7335–7340 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lai, L. et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295, 1089–1092 (2002).
  Article CAS PubMed Google Scholar
• Phelps, C.J. et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299, 411–414 (2003).
  Article CAS PubMed Google Scholar
• Yamada, K. et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 11, 32–34 (2005).
  Article CAS PubMed Google Scholar
• Kuwaki, K. et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11, 29–31 (2005).
  Article CAS PubMed Google Scholar
• Patience, C., Takeuchi, Y. & Weiss, R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3, 282–286 (1997).
  Article CAS PubMed Google Scholar
• Paradis, K. et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285, 1236–1241 (1999).
  Article CAS PubMed Google Scholar
• Scobie, L. et al. Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine. J. Virol. 78, 2502–2509 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wobus, A.M. & Boheler, K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635–678 (2005).
  Article CAS PubMed Google Scholar
• Freed, C.R. et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710–719 (2001).
  Article CAS PubMed Google Scholar
• Sarwal, M. et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349, 125–138 (2003).
  Article CAS PubMed Google Scholar